Page last updated: 2024-10-27

fluconazole and Essential Polyarteritis

fluconazole has been researched along with Essential Polyarteritis in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
" The dosage was increased (800 mg/day) following laboratory diagnosis of C."1.40Cryptococcus neoformans meningoencephalitis in a patient with polyarteritis nodosa. ( Buchta, V; Drahošová, M; Kutová, R; Mottl, R; Plíšek, S; Prášil, P; Vejsová, M, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchta, V1
Prášil, P1
Vejsová, M1
Mottl, R1
Kutová, R1
Drahošová, M1
Plíšek, S1

Other Studies

1 other study available for fluconazole and Essential Polyarteritis

ArticleYear
Cryptococcus neoformans meningoencephalitis in a patient with polyarteritis nodosa.
    Folia microbiologica, 2014, Volume: 59, Issue:6

    Topics: Antifungal Agents; Cryptococcus neoformans; Fatal Outcome; Fluconazole; Humans; Male; Meningoencepha

2014